JonesTrading analyst Soumit Roy reiterated a Buy rating on Cassava Sciences (SAVA - Research Report) today and set a price target of $100.00. The company's shares opened today at $30.05.According to TipRanks, Roy is a 4-star analyst with an average return of 5.1% and a 34.18% success rate. Roy covers the Healthcare sector, focusing on stocks such as Mirati Therapeutics, Aileron Therapeutics, and Adicet Bio.In addition to JonesTrading, Cassava Sciences also received a Buy from B.Riley Financial's Mayank Mamtani in a report issued on August 11. However, on August 4, Univest Securities maintained a Sell rating on Cassava Sciences (NASDAQ: SAVA).
https://www.tipranks.com/news/blurbs/cassava-sciences-sava-receives-a-buy-from-jonestrading?utm_source=advfn.com&utm_medium=referral
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Cassava Sciences Charts.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Cassava Sciences Charts.